GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT3) » Definitions » Cyclically Adjusted PB Ratio

Sartorius AG (XTER:SRT3) Cyclically Adjusted PB Ratio : 13.40 (As of Apr. 29, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG Cyclically Adjusted PB Ratio?

As of today (2024-04-29), Sartorius AG's current share price is €290.20. Sartorius AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €21.66. Sartorius AG's Cyclically Adjusted PB Ratio for today is 13.40.

The historical rank and industry rank for Sartorius AG's Cyclically Adjusted PB Ratio or its related term are showing as below:

XTER:SRT3' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 12.31   Med: 22.63   Max: 84.11
Current: 14.05

During the past years, Sartorius AG's highest Cyclically Adjusted PB Ratio was 84.11. The lowest was 12.31. And the median was 22.63.

XTER:SRT3's Cyclically Adjusted PB Ratio is ranked worse than
95.61% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 2.1 vs XTER:SRT3: 14.05

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sartorius AG's adjusted book value per share data for the three months ended in Mar. 2024 was €39.044. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €21.66 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sartorius AG Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sartorius AG's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Cyclically Adjusted PB Ratio Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.21 41.14 49.56 26.59 17.26

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.61 18.28 17.81 17.26 17.02

Competitive Comparison of Sartorius AG's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Sartorius AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Cyclically Adjusted PB Ratio falls into.



Sartorius AG Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sartorius AG's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=290.20/21.66
=13.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Sartorius AG's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=39.044/123.6675*123.6675
=39.044

Current CPI (Mar. 2024) = 123.6675.

Sartorius AG Quarterly Data

Book Value per Share CPI Adj_Book
201406 5.379 99.543 6.683
201409 5.722 99.823 7.089
201412 5.836 99.543 7.250
201503 6.819 99.717 8.457
201506 6.965 100.417 8.578
201509 7.345 100.417 9.046
201512 7.571 99.717 9.389
201603 7.786 100.017 9.627
201606 7.589 100.717 9.318
201609 7.963 101.017 9.749
201612 8.476 101.217 10.356
201703 8.942 101.417 10.904
201706 8.463 102.117 10.249
201709 8.722 102.717 10.501
201712 9.034 102.617 10.887
201803 9.281 102.917 11.152
201806 9.423 104.017 11.203
201809 9.942 104.718 11.741
201812 10.829 104.217 12.850
201903 10.863 104.217 12.890
201906 11.281 105.718 13.196
201909 12.103 106.018 14.118
201912 11.849 105.818 13.848
202003 12.527 105.718 14.654
202006 12.429 106.618 14.417
202009 12.896 105.818 15.071
202012 15.076 105.518 17.669
202103 16.464 107.518 18.937
202106 17.832 108.486 20.327
202109 18.038 109.435 20.384
202112 18.421 110.384 20.638
202203 20.868 113.968 22.644
202206 24.353 115.760 26.016
202209 27.438 118.818 28.558
202212 29.084 119.345 30.137
202303 28.167 122.402 28.458
202306 29.771 123.140 29.898
202309 30.213 124.195 30.085
202312 30.214 123.668 30.214
202403 39.044 123.668 39.044

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sartorius AG  (XTER:SRT3) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sartorius AG Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG (XTER:SRT3) Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.
Executives
Dr. Joachim Kreuzburg Board of Directors

Sartorius AG (XTER:SRT3) Headlines

No Headlines